Full 5th Circ. Redo Sought In Sanofi Chemo Hair Loss Suit
A Sanofi patient has asked the full Fifth Circuit to review the dismissal of her allegations the pharmaceutical giant failed to warn that its chemotherapy drug Taxotere carried a risk of...To view the full article, register now.
Already a subscriber? Click here to view full article